[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 3, Issue 11 (Winter 2017) ::
Caspian.J.Neurol.Sci 2017, 3(11): 214-221 Back to browse issues page
The Serum Amyloid β Level in Multiple Sclerosis: A Case- Control Study
Masoud Etemadifar , Mozhgan Ghadimi , Keyvan Ghadimi , Fereshteh Alsahebfosoul
Iranian Multiple Sclerosis and Neuroimmunology Research Center, Isfahan, Iran; keyvanghadimi@yahoo.com
Abstract:   (26 Views)
Background: Multiple sclerosis (MS) is one of the most common autoimmune diseases in adults that cause disability in patients. Different studies were conducted on more rapid diagnosis of the disease such as measuring serum or cerebrospinal fluid (CSF) contents.
Objectives: The current study aimed at measuring amyloid β (Aβ) serum levels in patients with relapsing-remitting MS.
Materials and Methods: In the current case-control study, the serum levels of Aβ were measured in 48 patients with RRMS and 33 healthy controls using the enzyme-linked immunosorbent assay (ELISA) technique in Isfahan, Iran, from 2014 to 2016. Data analysis was conducted with SPSS.
Results: The mean serum level of Aβ in the case (patients with RRMS) and control groups were 192.75±125.65 and 128.11±85.20 pg/mL, respectively; so serum Aβ levels in the RRMS group was significantly higher than healthy controls (p=0.02). Also, there was a positive significant correlation between the serum Aβ levels and the expanded disability status scale (EDSS) (r=+0.85, p<0.0001).
Conclusions: Owing to the increase of serum Aβ level in patients with RRMS and its significant increase in severe MS cases (higher EDSS scores), so serum Aβ level can be considered as a marker for MS and its progression.
Keywords: Multiple Sclerosis, Amyloid, Enzyme-Linked Immunosorbent Assay
Full-Text [PDF 538 kb]   (18 Downloads)    
Type of Study: Research | Subject: Special
Add your comments about this article
Your username or Email:

Write the security code in the box >



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Etemadifar M, Ghadimi M, Ghadimi K, Alsahebfosoul F. The Serum Amyloid β Level in Multiple Sclerosis: A Case- Control Study . Caspian.J.Neurol.Sci. 2017; 3 (11) :214-221
URL: http://cjns.gums.ac.ir/article-1-204-en.html
Volume 3, Issue 11 (Winter 2017) Back to browse issues page
مجله علوم اعصاب کاسپین Caspian Journal of Neurological Sciences

   The journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Persian site map - English site map - Created in 0.141 seconds with 823 queries by yektaweb 3525